Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Neratinib
Neratinib
698387-09-6
|
556.199
|
5.147
Neratinib is a tyrosine kinase inhibitor which exhibits antitumor action against Epidermal Growth Factor Receptor, HER2, and Human Epidermal Growth Factor Receptor 4 (HER4) postive carcinomas. It is used to treat breast cancer that over expresses the HER2 receptor.
HKI-272 | neratinib | nerlynx
Neratinib is a tyrosine kinase inhibitor which exhibits antitumor action against Epidermal Growth Factor Receptor, HER2, and Human Epidermal Growth Factor Receptor 4 (HER4) postive carcinomas. It is used to treat breast cancer that over expresses the HER2 receptor.
HKI-272 | neratinib | nerlynx
$41/5 mg
(EBC)
1
CAS:915942-22-2
0
CAS:698387-09-6
0
We provide 0 compound for Neratinib